127 related articles for article (PubMed ID: 21115928)
21. Reassessing the current TNM lymph node staging for renal cell carcinoma.
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
23. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
24. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
[TBL] [Abstract][Full Text] [Related]
25. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
26. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
[TBL] [Abstract][Full Text] [Related]
28. [Extensive nephrectomy in severe forms of cancer of the kidney in the adult].
Choquenet C; Foldes P; Dufour B
Ann Urol (Paris); 1986; 20(6):427-32. PubMed ID: 3566201
[TBL] [Abstract][Full Text] [Related]
29. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
30. Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.
Schrader AJ; Rustemeier J; Varga Z; Hegele A; Olbert PJ; Frohme C; Hofmann R
Int J Urol; 2009 Sep; 16(9):718-22. PubMed ID: 19659680
[TBL] [Abstract][Full Text] [Related]
31. Survival data justifies resection for pancreatic metastases.
Strobel O; Hackert T; Hartwig W; Bergmann F; Hinz U; Wente MN; Fritz S; Schneider L; Büchler MW; Werner J
Ann Surg Oncol; 2009 Dec; 16(12):3340-9. PubMed ID: 19777190
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
33. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.
Gunawan B; von Heydebreck A; Fritsch T; Huber W; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2003 Oct; 63(19):6200-5. PubMed ID: 14559804
[TBL] [Abstract][Full Text] [Related]
36. [Renal cell carcinoma with regional lymph node metastasis].
Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1995 Jun; 41(6):433-8. PubMed ID: 7645451
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
38. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
39. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
el-Naggar AK; Pathak S
Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
